Market Overview:
The global myocardial perfusion imaging (MPI) testing market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of cardiovascular diseases, rising geriatric population, and technological advancements in MPI testing equipment. Based on type, the global MPI testing market is segmented into stress myocardial perfusion imaging (MPI) and resting myocardial perfusion imaging (MPI). The stress MPI segment is expected to grow at a higher CAGR than the resting MPI segment during the forecast period. This can be attributed to factors such as growing awareness about early diagnosis and treatment of heart diseases and increasing number of cardiac patients who are candidates for stress tests. Based on application, the global MPI testing market is divided into hospitals, clinics, ambulatory surgery centers (ASCs), and other applications. The hospitals segment accounted for majority share of the global MPI testing market in 2017 owing to high prevalence of cardiovascular diseases among hospitalized patients across all regions studied in this research study. However, with increasing demand for outpatient care services due to changing lifestyle patterns and growing preference for minimally invasive procedures over traditional open-heart surgeries;the ASCs segment is projectedto register highest CAGR during 2018-2030 .
 Testing Industry Outlook.svg)
Product Definition:
Myocardial perfusion imaging (MPI) is a nuclear medicine procedure that uses radioactive tracers to assess blood flow and function in the heart muscle. MPI can help your doctor determine if you have coronary artery disease (CAD) or other heart problems.
Stress Myocardial Perfusion Imaging (MPI):
Stress myocardial perfusion imaging (MPI) testing is a new noninvasive method for the diagnosis of heart failure. It utilizes an MRI technique to evaluate the function of the heart in response to exercise stress. This test helps detect and measure abnormalities in cardiac performance that may not show up on standard EKG or stress ECG tracings.
Resting Myocardial Perfusion Imaging (MPI):
RPMI is a nuclear medicine test that uses a special camera to take images of the heart. The images show whether or not the heart is able to function properly. This test helps detect coronary artery disease, which may cause chest pain (angina pectoris) and can lead to a heart attack if not treated.
Application Insights:
Based on application, the global myocardial perfusion imaging market is segmented into hospitals, clinics and ambulatory surgery centers. The clinics segment dominated the market in 2017 owing to factors such as increasing awareness of MPI testing among cardiologists and availability of advanced equipment at low costs. In addition, an increase in the number of cardiology practices has also positively influenced this growth.
The hospital segment is expected to grow at a significant rate during the forecast period due to factors such as rising prevalence of cardiac diseases and technological advancements that have made it easier for patients suffering from these diseases to access MPI tests at hospitals or clinical settings with minimal cost involved. This factor will further boost industry growth over the next few years since most cardiovascular procedures are performed during active stages of life where patients require frequent medical checkups or monitoring for complications arising out-of-hospital.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, favorable government initiatives, and high adoption rate of technologically advanced products. For instance, CardioSTAT MPI system by Abbott is one of the most popular systems used for stress and rest MPI testing in this region. In addition, favorable reimbursement policies are also responsible for its large share in North America.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to increasing prevalence of cardiac disorders coupled with rising healthcare expenditure levels in emerging countries such as China & India & Japan (ICIJ). Moreover, growing medical tourism industry due to low cost treatment options will also boost demand during future years (The Economist Intelligence Unit (EIU) 2014).
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs)
- Growing geriatric population
- Rising awareness about the benefits of early diagnosis and treatment of CVDs
- Technological advancements in MPI testing equipment and techniques
- Increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Myocardial Perfusion Imaging (MPI) Testing Market Research Report
By Type
Stress Myocardial Perfusion Imaging (MPI), Resting Myocardial Perfusion Imaging (MPI)
By Application
Hospitals, Clinics, Ambulatory Surgery Centers
By Companies
Siemens, Koninklijke Philips, Convergent Imaging, SurgicEye GmbH, Lantheus Medical Imaging, Spectrum Dynamics Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
186
Number of Tables & Figures
131
Customization Available
Yes, the report can be customized as per your need.
Global Myocardial Perfusion Imaging (MPI) Testing Market Report Segments:
The global Myocardial Perfusion Imaging (MPI) Testing market is segmented on the basis of:
Types
Stress Myocardial Perfusion Imaging (MPI), Resting Myocardial Perfusion Imaging (MPI)
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Ambulatory Surgery Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Siemens
- Koninklijke Philips
- Convergent Imaging
- SurgicEye GmbH
- Lantheus Medical Imaging
- Spectrum Dynamics Medical
 Testing Market Overview.svg)
Highlights of The Myocardial Perfusion Imaging (MPI) Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Stress Myocardial Perfusion Imaging (MPI)
- Resting Myocardial Perfusion Imaging (MPI)
- By Application:
- Hospitals
- Clinics
- Ambulatory Surgery Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Myocardial Perfusion Imaging (MPI) Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Testing Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Myocardial perfusion imaging (MPI) is a type of imaging that uses a contrast agent to image the blood flow in the heart. MPI can be used to assess heart function and diagnose cardiac diseases.
Some of the major companies in the myocardial perfusion imaging (mpi) testing market are Siemens, Koninklijke Philips, Convergent Imaging, SurgicEye GmbH, Lantheus Medical Imaging, Spectrum Dynamics Medical.
The myocardial perfusion imaging (mpi) testing market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Myocardial Perfusion Imaging (MPI) Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Myocardial Perfusion Imaging (MPI) Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Myocardial Perfusion Imaging (MPI) Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Myocardial Perfusion Imaging (MPI) Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Myocardial Perfusion Imaging (MPI) Testing Market Size & Forecast, 2020-2028
4.5.1 Myocardial Perfusion Imaging (MPI) Testing Market Size and Y-o-Y Growth
4.5.2 Myocardial Perfusion Imaging (MPI) Testing Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Stress Myocardial Perfusion Imaging (MPI)
5.2.2 Resting Myocardial Perfusion Imaging (MPI)
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Ambulatory Surgery Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Myocardial Perfusion Imaging (MPI) Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Myocardial Perfusion Imaging (MPI) Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Stress Myocardial Perfusion Imaging (MPI)
9.6.2 Resting Myocardial Perfusion Imaging (MPI)
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Ambulatory Surgery Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Stress Myocardial Perfusion Imaging (MPI)
10.6.2 Resting Myocardial Perfusion Imaging (MPI)
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Ambulatory Surgery Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Stress Myocardial Perfusion Imaging (MPI)
11.6.2 Resting Myocardial Perfusion Imaging (MPI)
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Ambulatory Surgery Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Stress Myocardial Perfusion Imaging (MPI)
12.6.2 Resting Myocardial Perfusion Imaging (MPI)
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Ambulatory Surgery Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Stress Myocardial Perfusion Imaging (MPI)
13.6.2 Resting Myocardial Perfusion Imaging (MPI)
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Ambulatory Surgery Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Myocardial Perfusion Imaging (MPI) Testing Market: Competitive Dashboard
14.2 Global Myocardial Perfusion Imaging (MPI) Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Siemens
14.3.2 Koninklijke Philips
14.3.3 Convergent Imaging
14.3.4 SurgicEye GmbH
14.3.5 Lantheus Medical Imaging
14.3.6 Spectrum Dynamics Medical
